Teresa DeLuca, a director of Surgery Partners, Inc., filed a Form 4 on August 19, 2026, disclosing the open-market purchase of 10,000 shares of common stock on August 18, 2026.

Key Highlights

  • Reporting person: Teresa DeLuca, identified as a Director of Surgery Partners, Inc.
  • Transaction: Purchase (transaction code P) of 10,000 shares of common stock on August 18, 2026.
  • Price: $14.35 weighted average price per share, as noted in the filing's footnote.
  • Resulting ownership: 66,843 shares of common stock held directly following the transaction.
  • Weighted average disclosure: The filing states DeLuca will provide full details of shares purchased at each separate price upon request to the issuer, any security holder, or SEC staff.

Teresa DeLuca's Direct Purchase of Surgery Partners Common Stock

According to the Form 4 filed with the SEC on August 19, 2026, Teresa DeLuca, serving as a Director of Surgery Partners, Inc. (NASDAQ:SGRY), acquired 10,000 shares of the company's common stock on August 18, 2026. The transaction was coded as a purchase (P) under Table I, covering non-derivative securities acquired, disposed of, or beneficially owned.

The filing reported the transaction price as a weighted average of $14.35 per share. A footnote in the filing clarifies that the reported price "is a weighted average price," and that DeLuca "undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price." The shares acquired are recorded as directly owned.

Following the reported transaction, the filing disclosed that DeLuca beneficially owns 66,843 shares of Surgery Partners common stock on a direct basis. No derivative securities transactions were reported in Table II of the filing. The Form 4 was signed by Jennifer Baldock as Attorney-in-Fact on August 19, 2026.

What Was Disclosed

The filing disclosed a direct open-market purchase of 10,000 shares of Surgery Partners common stock by Director Teresa DeLuca at a weighted average price of $14.35 per share on August 18, 2026, resulting in direct beneficial ownership of 66,843 shares.